← Leaderboards
Carlo Dilorenzo
Children'S Hosp Pittsburgh/Upmc Hlth Sys
$26,753
Attributed
$26,753
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$26,753 · 3
By mechanism
M01$26,753 · 3
Top collaborators
No co-investigators on record.
Most similar at Children'S Hosp Pittsburgh/Upmc Hlth Sys
Same institution · by research overlap
- Dorothy J Becker$40,929,090
- Glenna Winnie$0
- Regina I Jakacki$100,247
- Rakesh K. Sindhi$3,236,424
- Maria Kovacs$15,965,092
Others in their field
Top investigators on “Human Therapy Evaluation”
- Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
- David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barbara Driver · Westat, Inc.$206,347,735
- Carol Nesel · Westat$188,148,170
- Constance Ann Benson · University Of California, San Diego$179,950,251
Research focus
Human Therapy EvaluationChild (0-11)Clinical ResearchPediatricsDrug Adverse EffectDrug Screening /EvaluationGastrointestinal AgentsHuman SubjectAnorectal DisorderOral AdministrationPharmacokineticsLaxativePatient Oriented ResearchConstipationPolyethylene Glycols
Grant awards (8)
MIRALAX LAXATIVE VS PLACEBO IN CHILDREN WITH CHRONIC CONSTIPATION$21,258
M01 · FY2005 · RR
MiraLax Laxative vs. Placebo in Children with Chronic Constipation$5,495
M01 · FY2004 · RR
Pharmacokinetic study of R108512 in pediatric subjects with fecal retention$0
M01 · FY2002 · RR
Prucalopride in pediatric patients with fecal retention$0
M01 · FY2002 · RR
Pharmacokinetic study of R108512 in pediatric subjects with fecal retention$0
M01 · FY2001 · RR
Prucalopride in pediatric patients with fecal retention$0
M01 · FY2001 · RR
Pharmacokinetic study of R108512 in pediatric subjects with fecal retention$0
M01 · FY2000 · RR
Prucalopride in pediatric patients with fecal retention$0
M01 · FY2000 · RR